Discipline of Dermatology, Bosch Institute, Sydney Cancer Centre, University of Sydney, Sydney, NSW 2006, Australia.
Br J Dermatol. 2011 Jun;164(6):1221-7. doi: 10.1111/j.1365-2133.2011.10267.x. Epub 2011 May 13.
Background Nonmelanoma skin cancer is caused by exposure to ultraviolet radiation within sunlight. Actinic keratoses (AKs) are benign precursor lesions that can develop into invasive squamous cell carcinoma (SCC). Little is known about the molecular events that lead to human skin cancer progression from benign to invasive. Objectives To determine novel genes that may be involved in skin cancer progression based on data from an initial microarray screen of human skin cancers. Methods The SWI/SNF chromatin remodelling ATPase subunit BRM was identified as being downregulated in SCC but not AK compared with normal skin in our microarray screen. Therefore reverse transcription-polymerase chain reaction, gene methylation and protein expression was used to study BRM and its alternative ATPase subunit BRG1 in a range of human skin cancers. Results We found reduced levels of mRNA coding for BRM but not BRG1 in SCC. BRM mRNA levels in AK were similar to those in normal skin. Deregulation of BRM did not result from hypermethylation of CpG regions in the promoter of these genes. Both BRM and BRG1 protein was reduced by about 10-fold in 100% of SCC and basal cell carcinoma, but not in AK specimens examined. Conclusions BRM protein may be decreased due to low levels of mRNA, while BRG1 protein loss appears to be post-translational. BRM and BRG1 may be novel tumour suppressor genes for human skin cancer. They appear to be involved after development of benign lesions, and are downregulated during progression towards invasion.
非黑色素瘤皮肤癌是由阳光内的紫外线辐射引起的。光化性角化病(AK)是良性前体病变,可发展为侵袭性鳞状细胞癌(SCC)。人们对导致人类皮肤癌从良性进展为侵袭性的分子事件知之甚少。
根据来自人类皮肤癌初始微阵列筛选的数据,确定可能参与皮肤癌进展的新基因。
SWI/SNF 染色质重塑 ATP 酶亚基 BRM 在我们的微阵列筛选中在 SCC 中下调,但在 AK 中与正常皮肤相比没有下调。因此,使用逆转录-聚合酶链反应、基因甲基化和蛋白质表达来研究 BRM 及其替代 ATP 酶亚基 BRG1 在一系列人类皮肤癌中的作用。
我们发现 SCC 中编码 BRM 的 mRNA 水平降低,但 BRG1 的 mRNA 水平没有降低。AK 中的 BRM mRNA 水平与正常皮肤相似。这些基因启动子中 CpG 区域的异常甲基化不是 BRM 下调的原因。BRM 和 BRG1 蛋白在 100%的 SCC 和基底细胞癌中降低了约 10 倍,但在 AK 标本中没有降低。
BRM 蛋白可能由于低水平的 mRNA 而减少,而 BRG1 蛋白的丢失似乎是翻译后修饰的结果。BRM 和 BRG1 可能是人类皮肤癌的新抑癌基因。它们似乎在良性病变发展后参与,并且在向侵袭进展过程中下调。